Mendelian randomization as a tool to inform drug development using human genetics
Drug development is essential to the advancement of human health, however, the process is slow, costly, and at high risk of failure at all stages. A promising strategy for expediting and improving the probability of success in the drug development process is the use of naturally randomized human gen...
Main Authors: | Iyas Daghlas, Dipender Gill |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-01-01
|
Series: | Cambridge Prisms: Precision Medicine |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S2752614323000054/type/journal_article |
Similar Items
-
Using Mendelian randomization provides genetic insights into potential targets for sepsis treatment
by: Rui Xia, et al.
Published: (2024-04-01) -
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
by: Yaodan Bi, et al.
Published: (2023-08-01) -
Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study
by: Yu Cao, et al.
Published: (2023-09-01) -
TwoStepCisMR: A Novel Method and R Package for Attenuating Bias in <i>cis</i>-Mendelian Randomization Analyses
by: Benjamin Woolf, et al.
Published: (2022-08-01) -
Identification of potential drug targets for varicose veins: a Mendelian randomization analysis
by: Jianfeng Lin, et al.
Published: (2023-06-01)